|
Status |
Public on Jun 09, 2016 |
Title |
mRNA-seq from Nutlin-3a, doxorubicin, and DMSO treated HCT116 p21-/- cells |
Organism |
Homo sapiens |
Experiment type |
Expression profiling by high throughput sequencing
|
Summary |
We sequenced mRNA from HCT116 p21-/- cells treated with Nutlin-3a, doxorubicin, or DMSO for 24 h.
|
|
|
Overall design |
Examination of mRNA levels from HCT116 p21-/- cells treated with Nutlin-3a, doxorubicin, or DMSO for 24 h using four replicates each.
|
Web link |
http://nar.oxfordjournals.org/content/early/2016/06/13/nar.gkw523.full
|
|
|
Contributor(s) |
Fischer M, DeCaprio JA |
Citation(s) |
27280975 |
|
Submission date |
Feb 11, 2016 |
Last update date |
May 15, 2019 |
Contact name |
Martin Fischer |
E-mail(s) |
Martin.Fischer@leibniz-fli.de
|
Organization name |
Leibniz Institute on Aging - Fritz Lipmann Institute (FLI)
|
Department |
Computational Biology
|
Lab |
Steve Hoffmann
|
Street address |
Beutenbergstraße 11
|
City |
Jena |
State/province |
Thuringia |
ZIP/Postal code |
07745 |
Country |
Germany |
|
|
Platforms (1) |
GPL18573 |
Illumina NextSeq 500 (Homo sapiens) |
|
Samples (12)
|
|
Relations |
BioProject |
PRJNA311717 |
SRA |
SRP069968 |